These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 18334102

  • 1. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.
    Elliott S, Smith C.
    J Anal Toxicol; 2008 Mar; 32(2):172-7. PubMed ID: 18334102
    [Abstract] [Full Text] [Related]

  • 2. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H, Katagi M, Miki A, Shima N, Kamata T, Nishikawa M, Nakajima K, Tsuchihashi H.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May 25; 819(2):315-22. PubMed ID: 15833296
    [Abstract] [Full Text] [Related]

  • 3. In vivo interactions between BZP and TFMPP (party pill drugs).
    Antia U, Tingle MD, Russell BR.
    N Z Med J; 2009 Sep 25; 122(1303):29-38. PubMed ID: 19851418
    [Abstract] [Full Text] [Related]

  • 4. The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.
    Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P.
    Clin Toxicol (Phila); 2011 Mar 25; 49(3):131-41. PubMed ID: 21495881
    [Abstract] [Full Text] [Related]

  • 5. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.
    Vorce SP, Holler JM, Levine B, Past MR.
    J Anal Toxicol; 2008 Mar 25; 32(6):444-50. PubMed ID: 18652752
    [Abstract] [Full Text] [Related]

  • 6. Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
    Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI.
    J Med Toxicol; 2008 Dec 25; 4(4):254-7. PubMed ID: 19031377
    [Abstract] [Full Text] [Related]

  • 7. In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
    Dias da Silva D, Silva MJ, Moreira P, Martins MJ, Valente MJ, Carvalho F, Bastos ML, Carmo H.
    Arch Toxicol; 2017 Mar 25; 91(3):1413-1430. PubMed ID: 27358233
    [Abstract] [Full Text] [Related]

  • 8. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
    Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.
    Neuropsychopharmacology; 2005 Mar 25; 30(3):550-60. PubMed ID: 15496938
    [Abstract] [Full Text] [Related]

  • 9. [1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): emergence of two agents which lead to misuse].
    Lecompte Y, Roussel O, Perrin M.
    Ann Pharm Fr; 2008 Mar 25; 66(2):85-91. PubMed ID: 18570904
    [Abstract] [Full Text] [Related]

  • 10. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
    Dickson AJ, Vorce SP, Holler JM, Lyons TP.
    J Anal Toxicol; 2010 Oct 25; 34(8):464-9. PubMed ID: 21819791
    [Abstract] [Full Text] [Related]

  • 11. Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.
    Lee H, Wang GY, Curley LE, Kydd RR, Kirk IJ, Russell BR.
    Psychopharmacology (Berl); 2016 Aug 25; 233(15-16):2869-77. PubMed ID: 27289365
    [Abstract] [Full Text] [Related]

  • 12. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
    Yarosh HL, Katz EB, Coop A, Fantegrossi WE.
    Pharmacol Biochem Behav; 2007 Nov 25; 88(1):18-27. PubMed ID: 17651790
    [Abstract] [Full Text] [Related]

  • 13. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.
    Ann N Y Acad Sci; 2004 Oct 25; 1025():189-97. PubMed ID: 15542717
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.
    Lee H, Wang GY, Curley LE, Sollers JJ, Kydd RR, Kirk IJ, Russell BR.
    Psychopharmacology (Berl); 2016 Mar 25; 233(5):863-71. PubMed ID: 26630992
    [Abstract] [Full Text] [Related]

  • 15. Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: a case of effective industry self-regulation?
    Wilkins C, Sweetsur P.
    Int J Drug Policy; 2010 Jan 25; 21(1):86-90. PubMed ID: 19359158
    [Abstract] [Full Text] [Related]

  • 16. Analysis of amphetamine-type substances and piperazine analogues using desorption electrospray ionisation mass spectrometry.
    Stojanovska N, Kelly T, Tahtouh M, Beavis A, Fu S.
    Rapid Commun Mass Spectrom; 2014 Apr 15; 28(7):731-40. PubMed ID: 24573804
    [Abstract] [Full Text] [Related]

  • 17. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.
    de Boer D, Bosman IJ, Hidvégi E, Manzoni C, Benkö AA, dos Reys LJ, Maes RA.
    Forensic Sci Int; 2001 Sep 15; 121(1-2):47-56. PubMed ID: 11516887
    [Abstract] [Full Text] [Related]

  • 18. Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.
    Curley LE, Kydd RR, Robertson MC, Pillai A, McNair N, Lee H, Kirk IJ, Russell BR.
    Psychopharmacology (Berl); 2015 Aug 15; 232(16):2969-80. PubMed ID: 25893641
    [Abstract] [Full Text] [Related]

  • 19. Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI).
    Curley LE, Kydd RR, Kirk IJ, Russell BR.
    Psychopharmacology (Berl); 2013 Oct 15; 229(4):673-85. PubMed ID: 23666554
    [Abstract] [Full Text] [Related]

  • 20. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.
    Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A.
    Drug Alcohol Depend; 2005 Feb 14; 77(2):161-8. PubMed ID: 15664717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.